BLACU Stock

Profile

Full Name:

Bellevue Life Sciences Acquisition Corp.

Country:

United States

IPO:

10 February 2023

Indexes:

Not included

Description:

BLACU, or Bellevue Life Sciences Acquisit, is a special purpose acquisition company (SPAC) focused on investing in life sciences and healthcare companies. It aims to identify and merge with innovative firms to support their growth and development in the biotechnology and pharmaceutical sectors.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Bellevue Life Sciences Acquisition?
  • What is the ticker symbol for Bellevue Life Sciences Acquisition?
  • Does Bellevue Life Sciences Acquisition pay dividends?
  • What sector is Bellevue Life Sciences Acquisition in?
  • What industry is Bellevue Life Sciences Acquisition in?
  • What country is Bellevue Life Sciences Acquisition based in?
  • When did Bellevue Life Sciences Acquisition go public?
  • Is Bellevue Life Sciences Acquisition in the S&P 500?
  • Is Bellevue Life Sciences Acquisition in the NASDAQ 100?
  • Is Bellevue Life Sciences Acquisition in the Dow Jones?
  • When was Bellevue Life Sciences Acquisition's last earnings report?
  • When does Bellevue Life Sciences Acquisition report earnings?

What is the primary business of Bellevue Life Sciences Acquisition?

BLACU, or Bellevue Life Sciences Acquisit, is a special purpose acquisition company (SPAC) focused on investing in life sciences and healthcare companies. It aims to identify and merge with innovative firms to support their growth and development in the biotechnology and pharmaceutical sectors.

What is the ticker symbol for Bellevue Life Sciences Acquisition?

The ticker symbol for Bellevue Life Sciences Acquisition is NASDAQ:BLACU

Does Bellevue Life Sciences Acquisition pay dividends?

No, Bellevue Life Sciences Acquisition does not pay dividends

What sector is Bellevue Life Sciences Acquisition in?

Bellevue Life Sciences Acquisition is in the Financial Services sector

What industry is Bellevue Life Sciences Acquisition in?

Bellevue Life Sciences Acquisition is in the Shell Companies industry

What country is Bellevue Life Sciences Acquisition based in?

Bellevue Life Sciences Acquisition is headquartered in United States

When did Bellevue Life Sciences Acquisition go public?

Bellevue Life Sciences Acquisition's initial public offering (IPO) was on 10 February 2023

Is Bellevue Life Sciences Acquisition in the S&P 500?

No, Bellevue Life Sciences Acquisition is not included in the S&P 500 index

Is Bellevue Life Sciences Acquisition in the NASDAQ 100?

No, Bellevue Life Sciences Acquisition is not included in the NASDAQ 100 index

Is Bellevue Life Sciences Acquisition in the Dow Jones?

No, Bellevue Life Sciences Acquisition is not included in the Dow Jones index

When was Bellevue Life Sciences Acquisition's last earnings report?

Bellevue Life Sciences Acquisition's most recent earnings report was on 14 November 2024

When does Bellevue Life Sciences Acquisition report earnings?

The next expected earnings date for Bellevue Life Sciences Acquisition is 15 May 2025